Beta-cell-derived urocortin-3 contributes to glucose-regulated somatostatin and glucagon secretion in the mouse pancreas

Aims/Hypothesis. Glucagon secretion is impaired in both type 1 and type 2 diabetes. The mechanisms behind this dysregulation are incompletely understood. Urocortin-3 (UCN-3), a beta-cell-derived peptide, stimulates somatostatin (SST) secretion and may thereby regulate glucagon secretion. We investigated the mechanisms through which UCN-3 regulates pancreatic hormone secretion and examined the physiological contribution of endogenous UCN-3 to glucose-regulated hormone secretion. Methods. Pancreatic hormone secretion was studied using the isolated perfused mouse pancreas. The effects of exogenous and endogenous UCN-3 were investigated using selective antagonists of SST receptors (SSTR) and corticotropin-releasing hormone receptor 2 (CRHR2). In addition, the role of UCN-3 was examined in streptozotocin (STZ) treated mice. Results. Exogenous UCN-3stimulated somatostatin secretion and inhibited glucagon secretion in the mouse pancreas. Blockade of SSTRs completely abolished the glucagonostatic effect of UCN-3, demonstrating that inhibition of glucagon secretion is indirectly mediated through SST signaling. Moreover, CRHR2 antagonism prevented both UCN-3-induced SST secretion and inhibition of glucagon secretion, identifying CRHR2 as the key receptor mediating these effects. During acute glucose stimulation (3.5-10mM), CRHR2 antagonism reduced glucose-induced stimulation of SST and attenuated glucagon inhibition, indicating that endogenous UCN-3 participates in the acute islet response to hyperglycemia. However, during sustained hyperglycemia, CRHR2 antagonism reduced SST secretion without altering glucagon secretion. In STZ-treated mice, glucose-induced SST secretion was lost. Conclusions. Urocortin-3 regulated glucagon secretion indirectly through CRHR2-dependent stimulation of SST secretion. Endogenous UCN-3 contributes to the acute islet response to hyperglycemia, supporting a physiologically relevant beta-cell-to-delta-cell-to-alpha-cell paracrine axis in the mouse pancreas. This pathway is disrupted following beta-cell loss, suggesting a potential contribution to impaired islet hormone regulation in diabetes.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.18.767593
Primary Topic
Pancreatic function and diabetes
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beta-cell-derived urocortin-3 contributes to glucose-regulated somatostatin and glucagon secretion in the mouse pancreas

Daniel Bjørklund Andersen, METTE MARIE ROSENKILDE, Gianfranco Di Giuseppe, Teresa Mezza et al.
bioRxiv (Cold Spring Harbor Laboratory)
Pancreatic function and diabetes
preprint

Beta-cell-derived urocortin-3 contributes to glucose-regulated somatostatin and glucagon secretion in the mouse pancreas

Daniel Bjørklund Andersen, METTE MARIE ROSENKILDE, Gianfranco Di Giuseppe, Teresa Mezza, Jens Juul Holst, Jon Vergara Ucin
preprint en

Abstract

Aims/Hypothesis. Glucagon secretion is impaired in both type 1 and type 2 diabetes. The mechanisms behind this dysregulation are incompletely understood. Urocortin-3 (UCN-3), a beta-cell-derived peptide, stimulates somatostatin (SST) secretion and may thereby regulate glucagon secretion. We investigated the mechanisms through which UCN-3 regulates pancreatic hormone secretion and examined the physiological contribution of endogenous UCN-3 to glucose-regulated hormone secretion. Methods. Pancreatic hormone secretion was studied using the isolated perfused mouse pancreas. The effects of exogenous and endogenous UCN-3 were investigated using selective antagonists of SST receptors (SSTR) and corticotropin-releasing hormone receptor 2 (CRHR2). In addition, the role of UCN-3 was examined in streptozotocin (STZ) treated mice. Results. Exogenous UCN-3stimulated somatostatin secretion and inhibited glucagon secretion in the mouse pancreas. Blockade of SSTRs completely abolished the glucagonostatic effect of UCN-3, demonstrating that inhibition of glucagon secretion is indirectly mediated through SST signaling. Moreover, CRHR2 antagonism prevented both UCN-3-induced SST secretion and inhibition of glucagon secretion, identifying CRHR2 as the key receptor mediating these effects. During acute glucose stimulation (3.5-10mM), CRHR2 antagonism reduced glucose-induced stimulation of SST and attenuated glucagon inhibition, indicating that endogenous UCN-3 participates in the acute islet response to hyperglycemia. However, during sustained hyperglycemia, CRHR2 antagonism reduced SST secretion without altering glucagon secretion. In STZ-treated mice, glucose-induced SST secretion was lost. Conclusions. Urocortin-3 regulated glucagon secretion indirectly through CRHR2-dependent stimulation of SST secretion. Endogenous UCN-3 contributes to the acute islet response to hyperglycemia, supporting a physiologically relevant beta-cell-to-delta-cell-to-alpha-cell paracrine axis in the mouse pancreas. This pathway is disrupted following beta-cell loss, suggesting a potential contribution to impaired islet hormone regulation in diabetes.

bioRxiv (Cold Spring Harbor Laboratory)
Università Cattolica del Sacro Cuore (IT), University of Copenhagen (DK)
European Foundation for the Study of Diabetes, Novo Nordisk, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
Good health and well-being
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon